Inhalerx Ltd
ASX:IRX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.018
0.048
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| AU |
I
|
Inhalerx Ltd
ASX:IRX
|
5.4m AUD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
35.7B USD |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
19.4B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
7.3B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
43.7B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
25.6B CNY |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
272.9B INR |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
Market Distribution
| Min | -16 177 900% |
| 30th Percentile | -544.7% |
| Median | -27.7% |
| 70th Percentile | 3.1% |
| Max | 3 174 540% |
Other Profitability Ratios
Inhalerx Ltd
Glance View
InhaleRx Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing inhaled therapies and medicine delivery systems. The company offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. The company utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Inhalerx Ltd is -158.3%, which is above its 3-year median of -811.7%.
Over the last 3 years, Inhalerx Ltd’s Net Margin has increased from -819% to -158.3%. During this period, it reached a low of -3 713.1% on Dec 31, 2022 and a high of -84.9% on Jun 30, 2024.